CRIS Q3 2019 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+0.3% YoY

Gross Profit

$3M94.9% margin

Operating Income

-$5M-186.4% margin

Net Income

-$6M-225.4% margin

EPS (Diluted)

$-3.88

QoQ Revenue Growth

+36.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$684,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$68M

Stockholders' Equity

-$26M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+0.3%
Gross Profit	$3M	$3M	+0.7%
Operating Income	-$5M	-$6M	+17.0%
Net Income	-$6M	-$7M	+10.9%

Revenue Segments

Contra Revenue

-$50,000